Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine abnormalities in morbid obesity.

A Peiris1, A Kissebah

  • 1Medical College of Wisconsin Clinical Research Center, Milwaukee.

Gastroenterology Clinics of North America
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes.

Diabetologia·2005
Same author

The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome.

The Journal of clinical endocrinology and metabolism·2001
Same author

The cardiovascular and metabolic complications of HIV infection.

Cardiology in review·2001
Same author

Identification and functional analysis of novel human melanocortin-4 receptor variants.

Diabetes·1999
Same author

Bronchospasm secondary to replacement estrogen therapy.

Chest·1993
Same author

Living related donor kidney transplantation in Sri Lanka.

Transplantation proceedings·1992

Understanding hormonal changes in morbid obesity is key. Successful weight loss reverses these hormonal issues, improving health outcomes and reducing mortality risks.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Obesity Medicine

Background:

  • Morbid obesity is associated with significant hormonal alterations.
  • These hormonal changes can complicate patient management and increase health risks.
  • The secondary nature of some metabolic changes in obesity is not fully understood.

Purpose of the Study:

  • To highlight the importance of recognizing hormonal changes in morbid obesity.
  • To differentiate primary from secondary hormonal abnormalities.
  • To emphasize the role of weight loss in managing obesity-related hormonal dysfunction.

Main Methods:

  • Review of existing literature on hormonal changes in morbid obesity.
  • Analysis of studies demonstrating the secondary nature of metabolic changes through overfeeding.

Related Experiment Videos

  • Evaluation of the impact of weight loss on hormonal profiles.

    • Main Results:

    • Hormonal changes are common in morbid obesity and can mimic primary endocrine disorders.
    • Overfeeding studies confirm that some metabolic alterations are secondary to excess adiposity.
    • Significant weight loss leads to the reversal of most observed hormonal abnormalities.

    Conclusions:

    • Recognizing obesity-related hormonal changes is crucial for appropriate clinical management.
    • Weight loss is a primary therapeutic strategy for correcting secondary hormonal dysregulation in morbid obesity.
    • Addressing hormonal imbalances through weight management can reduce associated morbidity and mortality.